We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 03:20, 18 April 2017 (diff | hist) . . (0) . . SGLT-2 Inhibitor (current)
- 03:20, 18 April 2017 (diff | hist) . . (+5) . . SGLT-2 Inhibitor (→Administration)
- 03:20, 18 April 2017 (diff | hist) . . (+4) . . SGLT-2 Inhibitor (→Serious)
- 03:19, 18 April 2017 (diff | hist) . . (+4) . . SGLT-2 Inhibitor (→Common)
- 03:17, 18 April 2017 (diff | hist) . . (0) . . SGLT-2 inhibitors (Redirected page to SGLT-2 Inhibitor) (current)
- 03:16, 18 April 2017 (diff | hist) . . (+29) . . N SGLT-2 inhibitors (Redirected page to SGLT-2 inhibitor)
- 03:16, 18 April 2017 (diff | hist) . . (+27) . . Diabetes medications (current)
- 03:15, 18 April 2017 (diff | hist) . . (+729) . . N SGLT-2 Inhibitor (Created page with "==Administration== *Type: Diabetes medication *Canagliflozin (Invokana), Dapagliflozin (Farxiga), empagliflozin (Jardiance) are FDA approved for use in type 2 diabetes ==...")
- 03:01, 18 April 2017 (diff | hist) . . (+234) . . Diabetic ketoacidosis (→Evaluation) (current)
- 19:24, 26 November 2016 (diff | hist) . . (-7) . . Salicylate toxicity
- 02:58, 20 September 2016 (diff | hist) . . (-1) . . Theophylline toxicity (→Management)
- 18:50, 11 August 2016 (diff | hist) . . (-1) . . Carbamazepine toxicity (→Management)
- 18:50, 11 August 2016 (diff | hist) . . (+44) . . Carbamazepine toxicity (→Management)
- 17:55, 11 August 2016 (diff | hist) . . (+533) . . Carbamazepine toxicity (→Management)
- 17:44, 11 August 2016 (diff | hist) . . (+11) . . Carbamazepine toxicity (→Clinical Features)
- 17:38, 11 August 2016 (diff | hist) . . (+5) . . Carbamazepine toxicity (→Background)
- 17:27, 11 August 2016 (diff | hist) . . (+1) . . Electrical storm (→Management) (current)
- 17:22, 11 August 2016 (diff | hist) . . (+219) . . Lithium toxicity (updated fatality stats)
- 17:19, 11 August 2016 (diff | hist) . . (-116) . . Lithium toxicity
- 03:30, 15 July 2016 (diff | hist) . . (+45) . . Acetaminophen toxicity (→Clinical Features)
- 03:27, 15 July 2016 (diff | hist) . . (0) . . Template:Acute hepatitis causes (→Acute hepatitis)
- 03:26, 15 July 2016 (diff | hist) . . (+479) . . Acetaminophen toxicity (→Management)
- 03:20, 15 July 2016 (diff | hist) . . (0) . . Acetaminophen toxicity (→Clinical Features)
- 03:20, 15 July 2016 (diff | hist) . . (-18) . . Acetaminophen toxicity (→Clinical Features)
- 03:19, 15 July 2016 (diff | hist) . . (0) . . Acetaminophen toxicity (→Clinical Features)
- 03:18, 15 July 2016 (diff | hist) . . (+437) . . Acetaminophen toxicity
- 03:12, 15 July 2016 (diff | hist) . . (+2) . . Botulism (→Background) (current)
- 03:11, 15 July 2016 (diff | hist) . . (+1) . . Botulism (→Background)
- 00:12, 6 July 2016 (diff | hist) . . (+1) . . User:Carpenj (current)
- 02:03, 22 June 2016 (diff | hist) . . (+52) . . Isopropyl alcohol toxicity (→Background)
- 02:02, 22 June 2016 (diff | hist) . . (+105) . . Isopropyl alcohol toxicity (→Background)
- 19:47, 21 June 2016 (diff | hist) . . (0) . . Levamisole toxicity
- 05:46, 9 June 2016 (diff | hist) . . (+4) . . Antidotes
- 04:45, 9 June 2016 (diff | hist) . . (0) . . Isoniazid (Redirected page to INH toxicity) (current)
- 04:37, 9 June 2016 (diff | hist) . . (-58) . . Pyridoxine
- 04:37, 9 June 2016 (diff | hist) . . (-29) . . Pyridoxine (→Special Populations)
- 04:34, 9 June 2016 (diff | hist) . . (+170) . . Pyridoxine (→Pediatric Dosing)
- 04:33, 9 June 2016 (diff | hist) . . (+8) . . Pyridoxine (→Adult Dosing)
- 04:33, 9 June 2016 (diff | hist) . . (+242) . . Pyridoxine (→Pediatric Dosing)
- 04:29, 9 June 2016 (diff | hist) . . (+9) . . Isoniazid (Redirected page to INH Toxicity)
- 04:28, 9 June 2016 (diff | hist) . . (+16) . . N Isoniazid (Redirected page to INH)
- 04:28, 9 June 2016 (diff | hist) . . (+10) . . Pyridoxine (→See Also)
- 04:27, 9 June 2016 (diff | hist) . . (+132) . . Pyridoxine (→Adult Dosing)
- 04:26, 9 June 2016 (diff | hist) . . (+4) . . INH toxicity (→Pyridoxine)
- 04:24, 9 June 2016 (diff | hist) . . (+509) . . Pyridoxine (→Adult Dosing)
- 04:23, 9 June 2016 (diff | hist) . . (-50) . . Mushroom toxicity (→Treatment)
- 04:18, 9 June 2016 (diff | hist) . . (+28) . . Pyridoxine (→Administration)
- 04:16, 9 June 2016 (diff | hist) . . (+4) . . Antidotes
- 04:15, 9 June 2016 (diff | hist) . . (+14) . . Pyridoxine
- 04:15, 9 June 2016 (diff | hist) . . (+595) . . N Pyridoxine (Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Drug Ratings in...")
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
